Superior vena cava syndrome historical perspective: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Superior vena cava syndrome was first discovered by William Hunter (1718-1783), a Scottish obstetrician, in 1757 following as a complication of a syphilitic [[aortic aneurysm]]. | Superior vena cava syndrome was first discovered by William Hunter (1718-1783), a Scottish obstetrician, in 1757 following as a complication of a syphilitic [[aortic aneurysm]]. <ref name="wikihistory"> William Hunter. https://en.wikipedia.org/wiki/William_Hunter_%28anatomist%29 Accessed on December 11, 2016<ref> | ||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 17:11, 11 January 2016
|
Superior Vena Cava Syndrome Microchapters |
|
Differentiating Superior Vena Cava Syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Superior vena cava syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Superior vena cava syndrome historical perspective |
|
Superior vena cava syndrome historical perspective in the news |
|
Directions to Hospitals Treating Superior vena cava syndrome |
|
Risk calculators and risk factors for Superior vena cava syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Superior vena cava syndrome was first discovered by William Hunter (1718-1783), a Scottish obstetrician, in 1757 following as a complication of a syphilitic aortic aneurysm. <ref name="wikihistory"> William Hunter. https://en.wikipedia.org/wiki/William_Hunter_%28anatomist%29 Accessed on December 11, 2016<ref>
Historical Perspective
The Scottish obstetrician and anatomist, William Hunter, first described the superior vena cava syndrome in 1757, noting it was a complication of a syphilitic aortic aneurysm. In the past, it was a medical emergency and empiric radiation was given to shrink the tumor. With the advent of better medical therapy for some lung cancers and lymphoma and the low morbidity associated with diagnostic procedures, this approach has fallen out of favor.